Investigational Drug Services

Salt Lake City, Utah 84112

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Psoriatic, Duchenne Muscular Dystrophy

Studies at this site

• A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy — Stopped early
• An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy — Stopped early
• Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis — Completed